S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway

AcelRx Pharmaceuticals (ACRX) SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.

Recent AcelRx Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/01/2024
6:35 AM
AcelRx Pharmaceuticals (Filer)
TALPHERA, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
7:58 PM
Angotti Vincent J. (Reporting)
AcelRx Pharmaceuticals (Issuer)
TALPHERA, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
8:01 PM
ASADORIAN RAFFI (Reporting)
AcelRx Pharmaceuticals (Issuer)
TALPHERA, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
8:04 PM
Dasu Badri N (Reporting)
AcelRx Pharmaceuticals (Issuer)
TALPHERA, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
8:06 PM
Palmer Pamela P (Reporting)
AcelRx Pharmaceuticals (Issuer)
TALPHERA, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:40 PM
Angotti Vincent J. (Reporting)
AcelRx Pharmaceuticals (Issuer)
TALPHERA, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:42 PM
ASADORIAN RAFFI (Reporting)
AcelRx Pharmaceuticals (Issuer)
TALPHERA, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:44 PM
Palmer Pamela P (Reporting)
AcelRx Pharmaceuticals (Issuer)
TALPHERA, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:46 PM
Dasu Badri N (Reporting)
AcelRx Pharmaceuticals (Issuer)
TALPHERA, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:00 PM
Lind Global Fund II LP (Filed by)
AcelRx Pharmaceuticals (Subject)
TALPHERA, INC. (Subject)
Form SC 13G/A
02/06/2024
3:44 PM
AcelRx Pharmaceuticals (Filer)
TALPHERA, INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/29/2024
11:32 AM
AcelRx Pharmaceuticals (Filer)
TALPHERA, INC. (Filer)
Form D
Notice of Exempt Offering of Securities 
01/24/2024
5:03 AM
Harkey Wilmot B. (Reporting)
Mack Daniel (Reporting)
Nantahala Capital Management, LLC (Reporting)
AcelRx Pharmaceuticals (Issuer)
TALPHERA, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
4:22 PM
JAIN ABHINAV (Reporting)
AcelRx Pharmaceuticals (Issuer)
TALPHERA, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
4:21 PM
JAIN ABHINAV (Reporting)
AcelRx Pharmaceuticals (Issuer)
TALPHERA, INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/22/2024
4:12 PM
AcelRx Pharmaceuticals (Filer)
TALPHERA, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2024
5:01 AM
Harkey Wilmot B. (Reporting)
Mack Daniel (Reporting)
Nantahala Capital Management, LLC (Reporting)
AcelRx Pharmaceuticals (Issuer)
TALPHERA, INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/18/2024
7:35 AM
AcelRx Pharmaceuticals (Filer)
TALPHERA, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
8:17 AM
AcelRx Pharmaceuticals (Filer)
TALPHERA, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2023
7:11 AM
AcelRx Pharmaceuticals (Issuer)
ACELRX PHARMACEUTICALS INC (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:34 PM
AcelRx Pharmaceuticals (Issuer)
ACELRX PHARMACEUTICALS INC (Issuer)
Afable Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:35 PM
AcelRx Pharmaceuticals (Issuer)
ACELRX PHARMACEUTICALS INC (Issuer)
HOFFMAN STEPHEN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:25 PM
AcelRx Pharmaceuticals (Issuer)
ACELRX PHARMACEUTICALS INC (Issuer)
Bozilenko Marina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:33 PM
AcelRx Pharmaceuticals (Issuer)
ACELRX PHARMACEUTICALS INC (Issuer)
WAN MARK A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:19 PM
AcelRx Pharmaceuticals (Issuer)
ACELRX PHARMACEUTICALS INC (Issuer)
ADAMS ADRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:21 PM
AcelRx Pharmaceuticals (Issuer)
ACELRX PHARMACEUTICALS INC (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:23 PM
AcelRx Pharmaceuticals (Issuer)
ACELRX PHARMACEUTICALS INC (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
11:15 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form EFFECT
11/22/2023
3:38 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/22/2023
3:34 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/14/2023
5:07 AM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/20/2023
3:30 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
3:17 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2023
3:45 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form DEFA14A
10/05/2023
3:30 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2023
4:18 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
6:13 PM
AcelRx Pharmaceuticals (Issuer)
ACELRX PHARMACEUTICALS INC (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
5:34 AM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form DEF 14A
08/28/2023
5:35 AM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form DEFA14A
08/25/2023
3:45 PM
AcelRx Pharmaceuticals (Issuer)
ACELRX PHARMACEUTICALS INC (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
11:45 AM
AcelRx Pharmaceuticals (Subject)
ACELRX PHARMACEUTICALS INC (Subject)
Palmer Pamela P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/24/2023
3:23 PM
AcelRx Pharmaceuticals (Subject)
ACELRX PHARMACEUTICALS INC (Subject)
Palmer Pamela P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
11:15 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form EFFECT
08/09/2023
4:29 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form 424B7
08/02/2023
5:06 AM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/31/2023
8:47 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2023
1:07 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form D
Notice of Exempt Offering of Securities 
07/21/2023
7:15 AM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2023
5:20 AM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form 10-K/A
04/07/2023
2:37 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2023
9:49 AM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/16/2023
3:15 PM
AcelRx Pharmaceuticals (Filer)
ACELRX PHARMACEUTICALS INC (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2023
3:44 PM
AcelRx Pharmaceuticals (Issuer)
ACELRX PHARMACEUTICALS INC (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2023
3:45 PM
AcelRx Pharmaceuticals (Issuer)
ACELRX PHARMACEUTICALS INC (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ACRX) was last updated on 3/3/2024 by MarketBeat.com Staff